Heart Assist Devices at Medical City Dallas
Comprehensive and Collaborative Patient Care Management
Medical City Dallas Hospital Ventricular Assist Device Program was established in 1996 and offers bridge to transplant (BTT), destination therapy (DT), and bridge to recovery. Our multi-disciplinary team works together to promote a comprehensive range of services. We provide leading edge technology to offer new beginnings for patients with improvement in their NYHA classification, projected survival, and quality of life.
Who is a candidate for LVAD therapy?
Patients with end-stage congestive heart failure with NYHA Class IIIB-IV symptoms on optimal medical therapy with one or more heart failure related hospital readmission in the past six months and with a life expectancy less than 24 months.
Benefits of Mechanical Circulatory Support
- Significantly reduce heart failure symptoms and help patients resume their daily lives
- Improve NYHA function class from Class IV to Class I or II
- Improve end-organ function
- Restore cardiac output and blood flow